Long-term effects of antihypertensive medications on bone mineral density in men older than 55 years
Authors A─ča├žayak K, G├╝ven S, Koparal M, G├╝ne┼č N, Atalay Y, At─▒lgan S
Received 14 January 2014
Accepted for publication 13 February 2014
Published 27 March 2014 Volume 2014:9 Pages 509—513
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Kamil Serkan A─čaçayak,1 Sedat Güven,2 Mahmut Koparal,1 Nedim Güne┼č,1 Yusuf Atalay,3 Serhat Atilgan1
1Department of Oral and Maxillofacial Surgery, 2Department of Prosthodontics, School of Dentistry, University of Dicle, Diyarbakir, Turkey; 3Department of Oral and Maxillofacial Surgery, School of Dentistry, University of Afyon Kocatepe, Afyon, Turkey
Introduction: In this study, we investigated the effects of long-term antihypertensive treatment with calcium channel blockers or beta blockers on the bone mineral density of maxilla, as determined by cone-beam computed tomography (CBCT).
Material and methods: This retrospective study was conducted on CBCT images of men older than 55 years who had received different dental indications. Data were grouped into three categories according to the antihypertensive medication history of the patients: group A included patients who had been taking beta-blocker treatment for more than 5 years, group B included patients who had been taking calcium channel blocker treatment for more than 5 years, and the control group included patients who had never used any hypertensive medications before.
Results: Statistically significant differences were observed between the beta blocker and calcium channel blocker groups.
Conclusion: In hypertension treatment, beta blockers may be preferred to calcium channel blockers in patients at high risk for osteoporosis and bone resorption.
Keywords: bone mineral density, CBCT, beta blockers, calcium channel blockers
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]